These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 307835)

  • 41. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 42. The consent form as a possible cause of side effects.
    Myers MG; Cairns JA; Singer J
    Clin Pharmacol Ther; 1987 Sep; 42(3):250-3. PubMed ID: 3621780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
    Nunn B; James FJ
    Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term study on gastrointestinal hemorrhage due to acetylsalicylic acid].
    Kaltwasser JP; Werner E
    Klin Wochenschr; 1971 Aug; 49(16):927-30. PubMed ID: 4998637
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevention of death from myocardial infarction by aspirin and other platelet active drugs.
    Elwood PC
    Clin Cardiol; 1979 Aug; 2(4):241-5. PubMed ID: 400517
    [No Abstract]   [Full Text] [Related]  

  • 46. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
    McCollum CN; Crow MJ; Rajah SM; Kester RC
    Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of aspirin on the pharmacokinetics of sulfinpyrazone in man.
    Buchanan MR; Endrenyi L; Giles AR; Rosenfeld J
    Thromb Res Suppl; 1983; 4():145-52. PubMed ID: 6579708
    [No Abstract]   [Full Text] [Related]  

  • 48. [Influence of Anturane on platelets aggregation. Comparative study with acetylsalicylic acid in patients with and without oral anticoagulant therapy].
    Fernández B de Quirós J; Dulp-Gollasch I; Hess H
    Rev Clin Esp; 1978 Nov; 151(3):219-22. PubMed ID: 740996
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative study of gastro-intestinal blood loss after antrafenine, aspirin and placebo in healthy volunteers (author's transl)].
    Bown RL; Martin BK; Gordon A; Seymour D; Rovei V; Gomeni C; Narbonne G; Coquelin JP
    Therapie; 1980; 35(6):685-91. PubMed ID: 6972101
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of chronic metoprolol and sulphinpyrazone on human lymphocyte beta-adrenoceptors.
    De Blasi A; Cortellaro M; Costantini C
    Br J Clin Pharmacol; 1984 Jul; 18(1):45-50. PubMed ID: 6331481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haemodynamic effects of sulphinpyrazone in experimental myocardial ischaemia.
    Russell DC
    Br J Pharmacol; 1981 Jan; 72(1):5-7. PubMed ID: 7225713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of aspirin-induced gastrointestinal bleeding with cimetidine.
    Welch RW; Bentch HL; Harris SC
    Gastroenterology; 1978 Feb; 74(2 Pt 2):459-63. PubMed ID: 340334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hazards of sulphinpyrazone.
    Mattingly D; Bradley M; Selley PJ
    Br Med J; 1978 Dec 23-30; 2(6154):1786-7. PubMed ID: 310703
    [No Abstract]   [Full Text] [Related]  

  • 54. Platelets, cardiac valves and sulphinpyrazone.
    Loeliger EA
    Thromb Haemost; 1982 Apr; 47(2):189. PubMed ID: 7101242
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin.
    Hunt JN; Franz DR
    Dig Dis Sci; 1981 Apr; 26(4):301-5. PubMed ID: 6972294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.
    Eller BT; Lynch JJ; Patterson E; Lucchesi BR
    Pharmacology; 1987; 34(2-3):121-30. PubMed ID: 3108907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A direct protective effect of sulphinpyrazone on ischaemic and reperfused rat hearts.
    Karmazyn M
    Br J Pharmacol; 1984 Sep; 83(1):221-6. PubMed ID: 6487890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentiation of warfarin action by sulphinpyrazone.
    Bailey RR; Reddy J
    Lancet; 1980 Feb; 1(8162):254. PubMed ID: 6101699
    [No Abstract]   [Full Text] [Related]  

  • 59. Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
    Rosenberg JC; Sell T
    Transplantation; 1975 Oct; 20(4):346-50. PubMed ID: 169611
    [No Abstract]   [Full Text] [Related]  

  • 60. Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone.
    Cerskus AL; Ali M; McDonald JW
    Thromb Res; 1980 Jun; 18(5):693-705. PubMed ID: 7414555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.